期刊文献+

人呼吸道合胞病毒亚单位疫苗的研究进展 被引量:5

下载PDF
导出
摘要 呼吸道合胞病毒(RSV)是在世界范围内引起婴幼儿下呼吸道感染的重要病毒之一,WHO要求对RSV要严加监控。RSV是副粘病毒科肺炎病毒属的单股负链非节段性RNA病毒。RSV疫苗的研制已有40多年的历史,但至今未被批准使用其疫苗。RSV膜表面融合蛋白F和黏附蛋白G两种糖蛋白,是激发机体产生保护性抗体的最主要的病毒抗原,亚单位疫苗的开发主要针对这两个蛋白。目前研究的有纯化的F糖蛋白(PFP)、BBG2Na、嵌合型F-G糖蛋白及纯化的F、G和基质蛋白M。本文就目前国内外所研究的RSV亚单位疫苗作一综述。
出处 《微生物学免疫学进展》 2009年第1期48-51,共4页 Progress In Microbiology and Immunology
  • 相关文献

参考文献24

  • 1Marc PG, Thomas C,Yuri P,et al. A review of vaccine research and development: human acute respiratory infections[ J]. Vaccine 2005,23:5708.
  • 2Tristram DA, Welliver RC, Mohar CK, et al. Immunogenicity and safety of respiratory syncytial virus virus subunit vaccine in seropositive children 18-36 months old [ J]. Infect Dis 1993, 167: 191-195.
  • 3Falsey A R. Safety and immunogenicity of a respiratory syncytial virus Subunitvaccin(PFP-2) in the institutionalized elderly[ J]. Vaccine 1997, 15(10) : 1130- 1132.
  • 4Munoz. F M. Safety and immunogen:city of respiratory syncytial vires purified fusion protein-2 vaccine in pregnant women[ J]. Vaccine 2003, 21:3465-3467.
  • 5Hancock GE, Smith JD, Hecrs KM. Serum neutralizing antibody titers of seropositive chimpanzees immunized with vaccines coformulated with natural fusion and attachment proteins of respiratory syncytial virus[J]. Infect Dis 2000,81:1786-1771.
  • 6Piedra PA,Cron SG, JewellA, et al. Immunogenicity of a new purifled fusionprotein vaccine to respiratory syncytial virasa muhi2center trial in childrenwith cystic fibrosis [ J]. Vaccine 2003,21 (19-20) :2448-2460.
  • 7Kim H J, Kim JK, Seo SB, et. al. Intranasal vaccination with peptides and cholera toxin subunit B as adjuvant to enhance mucosal and systemic immunity to respiratory syncytial virus [ J]. Arch Pharm Res 2007,30 ( 3 ) :366-371.
  • 8Shree R, Singh. lmmunogenicity and efficacy of recombinant RSV- F vaccine in a mouse model [J]. Vaccine 2007,14:6211- 6223.
  • 9Zhan XY. Respiratory syncytial virus (RSV)fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B[J]. Vaccine 2007,25(52) :8782- 8793.
  • 10Power UF, Nguyen TN, Rietveld E, et al. Satety and immunogenicity of a novel recombinantsubunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults [J]. Infect Dis 2001,184 : 1456-1460.

同被引文献76

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部